DAIDS Regulatory Compliance Center Logo Secure DAIDS RCC Document Collaboration Site
Home | About the RCC | Frequently Asked Questions | Contact Information | Useful Links | Web Site Update Log
Broadcast Memos
Regulatory Presentations
Policies and
Relevant Regulations
Protocol Development Information
Regulatory Information
Human Subjects Protection (HSP)
Protocol Registration
Safety and Pharmacovigilance
Case Report Form
(CRF) Management
Drug Risk List Table
NODRUG NAMES ( PREFERRED/TRADE )WORD
1 Abacavir Sulfate (Ziagen)
2 Atazanavir (Reyataz)
3 Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
4 Combivir (lamivudine/zidovudine)
5 Darunavir (Prezista)
6 Didanosine (Videx EC) Delayed-Release Capsules
7 Efavirenz (Sustiva)
8 Emtricitabine (Emtriva)
9 Enfuvirtide (Fuzeon)
10 Etravirine (Intelence)
11 Human Papillomavirus Quadrivalent Types 6, 11, 16 and 18 Vaccine, Recombinant (Gardasil)
12 Interleukin-2 (Proleukin)
13 Kaletra Tablet (Lopinavir/Ritonavir)
14 Lamivudine (Epivir)
15 Maraviroc (Selzentry)
16 Raltegravir (Isentress)
17 Ritonavir; (Norvir)
18 Stavudine (Zerit) Capsules, Oral Solution
19 Tenofovir Disoproxil fumarate (Viread)
20 Tipranavir (Aptivus)
21 Truvada (emtricitabine/tenofovir disoproxil fumarate)
22 Viramune (Nevirapine)
23 Zidovudine (Retrovir) tablets, capsules, syrup
Document Title Search

Search Help
RCC Quick Contacts
Drug Risk List Table
Package Inserts
Investigator Brochures
 
Latest News & Updates